| Identification | |
|---|---|
| Name | 16,17-Androstene-3-Ol |
| Accession Number | DB01889 (EXPT00580) |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 274.4409 |
| Groups | experimental |
| Monoisotopic Weight | 274.229665582 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Nuclear receptor subfamily 1 group I member 3 | |
|---|---|
| Name | Nuclear receptor subfamily 1 group I member 3 |
| Gene Name | NR1I3 |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | 1.25 |
| Id | Partner name | Gene Name | Score |
|---|---|---|---|
| 6105 | 3-oxo-5-beta-steroid 4-dehydrogenase | AKR1D1 | 0.1557 |
| 6228 | Nuclear receptor coactivator 1 | NCOA1 | 0.1303 |
| 459 | Retinoic acid receptor RXR-alpha | RXRA | 0.1201 |